表紙
市場調査レポート

卵巣癌向け診断製品:パイプライン分析

Ovarian Cancer - Pipeline Review, 2015

発行 GlobalData 商品コード 342291
出版日 ページ情報 英文 174 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
卵巣癌向け診断製品:パイプライン分析 Ovarian Cancer - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 174 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の、卵巣癌診断用の診断製品 (および関連製品) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・分野別・地域別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発の動き・業界動向などを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 卵巣癌向け診断製品の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 卵巣癌診断用診断製品:開発中のパイプライン製品 (企業別)

  • 卵巣癌向け診断製品の開発企業:パイプライン製品 (開発段階別)
  • 卵巣癌向け診断製品:開発段階別のパイプライン製品の一覧

第5章 卵巣癌向け診断製品の開発企業・製品の概要

  • A&G Pharmaceutical, Inc.
    • パイプライン製品および現在進行中の治験の概要
  • Abcodia Ltd.
  • Abnova Corporation
  • Adaptive Biotechnologies Corporation
  • Almac Diagnostics Limited
  • AroCell AB
  • Arrayit Diagnostics, Inc.
  • ArtemixRx
  • Aurelium BioPharma Inc. (Inactive)
  • Axela Inc.
  • Ayanda Biosystems S.A.
  • Becton, Dickinson and Company
  • Bioindustry Park Silvano Fumero S.p.A.
  • BioMark Diagnostics Inc.
  • Ceres Nanosciences, Inc.
  • Chronix Biomedical, Inc.
  • Clarient, Inc.
  • ClavGen Therapeutics LLC
  • Cleveland Diagnostics Inc.
  • Clovis Oncology, Inc.
  • Cornell University
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Dako A/S
  • Dana-Farber Cancer Institute, Inc.
  • diaDexus, Inc.
  • Eventus Diagnostics, Inc.
  • Exiqon A/S
  • Exosomics Siena SpA
  • Foundation Medicine, Inc.
  • Ganymed Pharmaceuticals AG
  • GeneNews Limited
  • Georgia Institute of Technology
  • GlycoZym
  • H. Lee Moffitt Cancer Center & Research Institute, Inc.
  • Ikonisys, Inc.
  • Inanovate (UK) Ltd.
  • IncellDx, Inc.
  • Innovative Health Diagnostics
  • Institut National de la Sante et de la Recherche Medicale
  • InterGenetics Incorporated
  • IV Diagnostics, Inc.
  • KIYATEC Inc.
  • Lab Discoveries Ltd.
  • Laboratorios SALVAT S.A.
  • Laboratory Corporation of America Holdings
  • Louisville Bioscience, Inc.
  • MabCure Inc.
  • Manalto Limited
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Metabolon, Inc.
  • Milagen, Inc.
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • National University of Singapore
  • Neogenix Oncology, Inc.
  • Novel Bio-spectrum Technologies, Inc.
  • NuCana BioMed Limited
  • Oncgnostics GmbH
  • Orion Genomics LLC
  • Oryzon Genomics S.A.
  • OTraces Inc.
  • OvaGene Oncology Inc.
  • PeriRx LLC
  • Pronota NV
  • Protagen AG
  • Proteomika
  • Provista Diagnostics Inc.
  • RCP Diagnostics, LLC (Inactive)
  • RiboMed Biotechnologies, Inc.
  • Rice University
  • Roche Diagnostics International Ltd.
  • Rosetta Genomics, Ltd.
  • Rush University Medical Center
  • SomaLogic, Inc.
  • Soricimed Biopharma Inc.
  • Stage I Diagnostics, Inc.
  • SurExam Life Science & Technology Co.
  • Target Discovery, Inc.
  • Teva Pharmaceutical Industries Limited
  • The Johns Hopkins University
  • The University of Adelaide
  • The University of Texas M. D. Anderson Cancer Center
  • Todos Medical
  • Transbiomed, SL
  • Universite de Montreal
  • University of South Florida
  • US Biomarkers, Inc.
  • Vermillion, Inc.
  • Vitatex Inc.
  • Vitruvian Biomedical, Inc.
  • Yale University

第6章 卵巣癌向け診断製品:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0074EPD

GlobalData's Medical Devices sector report, "Ovarian Cancer - Pipeline Review, 2015" provides an overview of Ovarian Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ovarian Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ovarian Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ovarian Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ovarian Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Ovarian Cancer Overview

3. Products under Development

  • 3.1. Ovarian Cancer - Pipeline Products by Stage of Development
  • 3.2. Ovarian Cancer - Pipeline Products by Territory
  • 3.3. Ovarian Cancer - Pipeline Products by Regulatory Path
  • 3.4. Ovarian Cancer - Pipeline Products by Estimated Approval Date
  • 3.5. Ovarian Cancer - Ongoing Clinical Trials

4. Ovarian Cancer - Pipeline Products under Development by Companies

  • 4.1. Ovarian Cancer Companies - Pipeline Products by Stage of Development
  • 4.2. Ovarian Cancer - Pipeline Products by Stage of Development

5. Ovarian Cancer Companies and Product Overview

  • 5.1. A&G Pharmaceutical, Inc. Company Overview
    • 5.1.1. A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Abcodia Ltd. Company Overview
    • 5.2.1. Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Abnova Corporation Company Overview
    • 5.3.1. Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Adaptive Biotechnologies Corporation Company Overview
    • 5.4.1. Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Almac Diagnostics Limited Company Overview
    • 5.5.1. Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. AroCell AB Company Overview
    • 5.6.1. AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Arrayit Diagnostics, Inc. Company Overview
    • 5.7.1. Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. ArtemixRx Company Overview
    • 5.8.1. ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Aurelium BioPharma Inc. (Inactive) Company Overview
    • 5.9.1. Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Axela Inc. Company Overview
    • 5.10.1. Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Ayanda Biosystems S.A. Company Overview
    • 5.11.1. Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Becton, Dickinson and Company Company Overview
    • 5.12.1. Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Bioindustry Park Silvano Fumero S.p.A. Company Overview
    • 5.13.1. Bioindustry Park Silvano Fumero S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. BioMark Diagnostics Inc. Company Overview
    • 5.14.1. BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Ceres Nanosciences, Inc. Company Overview
    • 5.15.1. Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Chronix Biomedical, Inc. Company Overview
    • 5.16.1. Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Clarient, Inc. Company Overview
    • 5.17.1. Clarient, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. ClavGen Therapeutics LLC Company Overview
    • 5.18.1. ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Cleveland Diagnostics Inc. Company Overview
    • 5.19.1. Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Clovis Oncology, Inc. Company Overview
    • 5.20.1. Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Cornell University Company Overview
    • 5.21.1. Cornell University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Courtagen Life Sciences, Inc. Company Overview
    • 5.22.1. Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. CS-Keys, Inc. Company Overview
    • 5.23.1. CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Dako A/S Company Overview
    • 5.24.1. Dako A/S Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Dana-Farber Cancer Institute, Inc. Company Overview
    • 5.25.1. Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. diaDexus, Inc. Company Overview
    • 5.26.1. diaDexus, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Eventus Diagnostics, Inc. Company Overview
    • 5.27.1. Eventus Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Exiqon A/S Company Overview
    • 5.28.1. Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Exosomics Siena SpA Company Overview
    • 5.29.1. Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Foundation Medicine, Inc. Company Overview
    • 5.30.1. Foundation Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Ganymed Pharmaceuticals AG Company Overview
    • 5.31.1. Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. GeneNews Limited Company Overview
    • 5.32.1. GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Georgia Institute of Technology Company Overview
    • 5.33.1. Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. GlycoZym Company Overview
    • 5.34.1. GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview
    • 5.35.1. H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Ikonisys, Inc. Company Overview
    • 5.36.1. Ikonisys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Inanovate (UK) Ltd. Company Overview
    • 5.37.1. Inanovate (UK) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. IncellDx, Inc. Company Overview
    • 5.38.1. IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Innovative Health Diagnostics Company Overview
    • 5.39.1. Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Institut National de la Sante et de la Recherche Medicale Company Overview
    • 5.40.1. Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. InterGenetics Incorporated Company Overview
    • 5.41.1. InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. IV Diagnostics, Inc. Company Overview
    • 5.42.1. IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. KIYATEC Inc. Company Overview
    • 5.43.1. KIYATEC Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Lab Discoveries Ltd. Company Overview
    • 5.44.1. Lab Discoveries Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Laboratorios SALVAT S.A. Company Overview
    • 5.45.1. Laboratorios SALVAT S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Laboratory Corporation of America Holdings Company Overview
    • 5.46.1. Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Louisville Bioscience, Inc. Company Overview
    • 5.47.1. Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. MabCure Inc. Company Overview
    • 5.48.1. MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Manalto Limited Company Overview
    • 5.49.1. Manalto Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. MDNA Life Sciences, Inc. Company Overview
    • 5.50.1. MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. MDxHealth SA Company Overview
    • 5.51.1. MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Metabolon, Inc. Company Overview
    • 5.52.1. Metabolon, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. Milagen, Inc. Company Overview
    • 5.53.1. Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Myriad Genetics, Inc. Company Overview
    • 5.54.1. Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. Nanosphere, Inc. Company Overview
    • 5.55.1. Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. National University of Singapore Company Overview
    • 5.56.1. National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. Neogenix Oncology, Inc. Company Overview
    • 5.57.1. Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. Novel Bio-spectrum Technologies, Inc. Company Overview
    • 5.58.1. Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. NuCana BioMed Limited Company Overview
    • 5.59.1. NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. Oncgnostics GmbH Company Overview
    • 5.60.1. Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. Orion Genomics LLC Company Overview
    • 5.61.1. Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. Oryzon Genomics S.A. Company Overview
    • 5.62.1. Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. OTraces Inc. Company Overview
    • 5.63.1. OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. OvaGene Oncology Inc. Company Overview
    • 5.64.1. OvaGene Oncology Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65. PeriRx LLC Company Overview
    • 5.65.1. PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66. Pronota NV Company Overview
    • 5.66.1. Pronota NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67. Protagen AG Company Overview
    • 5.67.1. Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68. Proteomika Company Overview
    • 5.68.1. Proteomika Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69. Provista Diagnostics Inc. Company Overview
    • 5.69.1. Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70. RCP Diagnostics, LLC (Inactive) Company Overview
    • 5.70.1. RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.71. RiboMed Biotechnologies, Inc. Company Overview
    • 5.71.1. RiboMed Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.72. Rice University Company Overview
    • 5.72.1. Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.73. Roche Diagnostics International Ltd. Company Overview
    • 5.73.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.74. Rosetta Genomics, Ltd. Company Overview
    • 5.74.1. Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.75. Rush University Medical Center Company Overview
    • 5.75.1. Rush University Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.76. SomaLogic, Inc. Company Overview
    • 5.76.1. SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.77. Soricimed Biopharma Inc. Company Overview
    • 5.77.1. Soricimed Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.78. Stage I Diagnostics, Inc. Company Overview
    • 5.78.1. Stage I Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.79. SurExam Life Science & Technology Co. Company Overview
    • 5.79.1. SurExam Life Science & Technology Co. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.80. Target Discovery, Inc. Company Overview
    • 5.80.1. Target Discovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.81. Teva Pharmaceutical Industries Limited Company Overview
    • 5.81.1. Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.82. The Johns Hopkins University Company Overview
    • 5.82.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.83. The University of Adelaide Company Overview
    • 5.83.1. The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview
  • 5.84. The University of Texas M. D. Anderson Cancer Center Company Overview
    • 5.84.1. The University of Texas M. D. Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.85. Todos Medical Company Overview
    • 5.85.1. Todos Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.86. Transbiomed, SL Company Overview
    • 5.86.1. Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.87. Universite de Montreal Company Overview
    • 5.87.1. Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview
  • 5.88. University of South Florida Company Overview
    • 5.88.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.89. US Biomarkers, Inc. Company Overview
    • 5.89.1. US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.90. Vermillion, Inc. Company Overview
    • 5.90.1. Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.91. Vitatex Inc. Company Overview
    • 5.91.1. Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.92. Vitruvian Biomedical, Inc. Company Overview
    • 5.92.1. Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.93. Yale University Company Overview
    • 5.93.1. Yale University Pipeline Products & Ongoing Clinical Trials Overview

6. Ovarian Cancer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Ovarian Cancer - Pipeline Products by Stage of Development
  • Table 2: Ovarian Cancer - Pipeline Products by Territory
  • Table 3: Ovarian Cancer - Pipeline Products by Regulatory Path
  • Table 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date
  • Table 5: Ovarian Cancer - Ongoing Clinical Trials
  • Table 6: Ovarian Cancer Companies - Pipeline Products by Stage of Development
  • Table 7: Ovarian Cancer - Pipeline Products by Stage of Development
  • Table 8: A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Companion Diagnostic Test - Ovarian Cancer - Product Status
  • Table 10: Companion Diagnostic Test - Ovarian Cancer - Product Description
  • Table 11: Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: ROCA Diagnostic Test - Product Status
  • Table 13: ROCA Diagnostic Test - Product Description
  • Table 14: Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Biomarker Test - Ovarian Cancer - Product Status
  • Table 16: Biomarker Test - Ovarian Cancer - Product Description
  • Table 17: Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: tilSEQ Assay - Product Status
  • Table 19: tilSEQ Assay - Product Description
  • Table 20: Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Diagnostic Test - Ovarian Cancer - Product Status
  • Table 22: Diagnostic Test - Ovarian Cancer - Product Description
  • Table 23: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: TK 210 Assay - Ovarian Cancer - Product Status
  • Table 25: TK 210 Assay - Ovarian Cancer - Product Description
  • Table 26: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: OvaDx - Product Status
  • Table 28: OvaDx - Product Description
  • Table 29: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: ArtemixRx Prognostic Test - Ovarian Cancer - Product Status
  • Table 31: ArtemixRx Prognostic Test - Ovarian Cancer - Product Description
  • Table 32: Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: MMD ELISA Test For Ovarian Cancer - Product Status
  • Table 34: MMD ELISA Test For Ovarian Cancer - Product Description
  • Table 35: Ovarian Cancer Screening Test - Product Status
  • Table 36: Ovarian Cancer Screening Test - Product Description
  • Table 37: Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Multiplex Ovarian Cancer Biomarker Assay - Product Status
  • Table 39: Multiplex Ovarian Cancer Biomarker Assay - Product Description
  • Table 40: Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Diagnostic Test - Ovarian Cancer - Product Status
  • Table 42: Diagnostic Test - Ovarian Cancer - Product Description
  • Table 43: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Diagnostic Test - Ovarian Cancer - Product Status
  • Table 45: Diagnostic Test - Ovarian Cancer - Product Description
  • Table 46: Bioindustry Park Silvano Fumero S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Diagnostic Kit - Ovarian Cancer - Product Status
  • Table 48: Diagnostic Kit - Ovarian Cancer - Product Description
  • Table 49: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Biomarker Assay - Ovarian Cancer - Product Status
  • Table 51: Biomarker Assay - Ovarian Cancer - Product Description
  • Table 52: Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Nanotrap Ovarian Cancer Biomarker Test - Product Status
  • Table 54: Nanotrap Ovarian Cancer Biomarker Test - Product Description
  • Table 55: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Companion Diagnostic Test - Ovarian Cancer - Product Status
  • Table 57: Companion Diagnostic Test - Ovarian Cancer - Product Description
  • Table 58: Clarient, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Ovatax - Product Status
  • Table 60: Ovatax - Product Description
  • Table 61: ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Prognostic Assay - Ovarian Cancer - Product Status
  • Table 63: Prognostic Assay - Ovarian Cancer - Product Description
  • Table 64: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Blood-Based Diagnostic Test - Ovarian Cancer - Product Status
  • Table 66: Blood-Based Diagnostic Test - Ovarian Cancer - Product Description
  • Table 67: Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Rucaparib Companion Diagnostic Test - Product Status
  • Table 69: Rucaparib Companion Diagnostic Test - Product Description
  • Table 70: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Non-Invasive Diagnostic Test - Ovarian Cancer - Product Status
  • Table 72: Non-Invasive Diagnostic Test - Ovarian Cancer - Product Description
  • Table 73: Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Ovarian Cancer Diagnostic Panel - Product Status
  • Table 75: Ovarian Cancer Diagnostic Panel - Product Description
  • Table 76: CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: caPCNA - Ovarian Cancer - Product Status
  • Table 78: caPCNA - Ovarian Cancer - Product Description
  • Table 79: Dako A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: MK-8109 Companion Diagnostic Test - Product Status
  • Table 81: MK-8109 Companion Diagnostic Test - Product Description
  • Table 82: Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Biomarker Assay - Ovarian Carcinoma - Product Status
  • Table 84: Biomarker Assay - Ovarian Carcinoma - Product Description
  • Table 85: diaDexus, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: B7-H4 Assay - Product Status
  • Table 87: B7-H4 Assay - Product Description
  • Table 88: DcR3 (DD-C248) Assay - Product Status
  • Table 89: DcR3 (DD-C248) Assay - Product Description
  • Table 90: MIC-1 (DD-X065) Assay - Product Status
  • Table 91: MIC-1 (DD-X065) Assay - Product Description
  • Table 92: Spondin-2 (DD-P108) Assay - Product Status
  • Table 93: Spondin-2 (DD-P108) Assay - Product Description
  • Table 94: Eventus Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Octava Test - Ovarian Cancer - Product Status
  • Table 96: Octava Test - Ovarian Cancer - Product Description
  • Table 97: Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: miRNA test-Ovarian - Product Status
  • Table 99: miRNA test-Ovarian - Product Description
  • Table 100: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: EXOTEST Ovarian - Product Status
  • Table 102: EXOTEST Ovarian - Product Description
  • Table 103: Foundation Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Companion Diagnostic Assay - Rucaparib - Product Status
  • Table 105: Companion Diagnostic Assay - Rucaparib - Product Description
  • Table 106: Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: IMAB027 Companion Diagnostic Test - Product Status
  • Table 108: IMAB027 Companion Diagnostic Test - Product Description
  • Table 109: GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Biomarker Diagnostic Test - Ovarian Cancer - Product Status
  • Table 111: Biomarker Diagnostic Test - Ovarian Cancer - Product Description
  • Table 112: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Mass Spectrometry Based Ovarian Cancer Test - Product Status
  • Table 114: Mass Spectrometry Based Ovarian Cancer Test - Product Description
  • Table 115: GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Diagnostic Assay - Ovarian Cancer - Product Status
  • Table 117: Diagnostic Assay - Ovarian Cancer - Product Description
  • Table 118: H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: Diagnostic Assay - Ovarian Cancer - Product Status
  • Table 120: Diagnostic Assay - Ovarian Cancer - Product Description
  • Table 121: Ikonisys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: oncoFISH ovarian - Product Status
  • Table 123: oncoFISH ovarian - Product Description
  • Table 124: Inanovate (UK) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: Diagnostic Test - Ovarian Cancer - Product Status
  • Table 126: Diagnostic Test - Ovarian Cancer - Product Description
  • Table 127: IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Ovarian Cancer - Pipeline Products by Stage of Development
  • Figure 2: Ovarian Cancer - Pipeline Products by Territory
  • Figure 3: Ovarian Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date
  • Figure 5: Ovarian Cancer - Ongoing Clinical Trials
Back to Top